Trump’s push to bring drug manufacturing back to the United States has sparked concerns across the industry, particularly for generic drugmakers ... as the charts below show.

US & Canada, May 09, 2025 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the global Generic Drugs Market is growing owing to patent expiry and loss of ...

Ottawa, Precedence Research, April 16, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the worldwide generic drugs market size was valued at USD 445.62 billion in 2024 and is projected ...

This launch is part of Sunshine Biopharma’s efforts to expand its presence in Canada’s generic drugs market ... is also engaged in proprietary drug development, working on treatments for ...

Generic drugs tend to be less expensive, as they don’t cost as much to develop. This is because brand-name medications are new drugs that require research, development, and clinical trials.

Viatris' fast-acting form of generic pain drug meloxicam met the main goals of two late-stage studies, the company said on Thursday, adding that it would seek the US FDA's marketing approval for the ...

"C-Path was built on the vision that no single entity can solve the challenges of the drug development process alone," said former C-Path CEO Dr. Woosley. "Over the last 20 years, C-Path has ...

Clinical trials are vital to drug development but often face challenges such as slow patient recruitment, high costs, and suboptimal trial designs. Today, artificial intelligence (AI) and real ...

Gantt charts are one of my favorite ways to gain visual project overviews. Whether you use Google Sheets or Excel, you can enjoy using several beginner-friendly templates for work, studying ...

Drug development is a notoriously slow, complex and costly process, with over 90% of drug candidates failing before reaching the market. A major cause of this inefficiency is the reliance on ...

Lupin is one of the first ANDA applicants and is eligible for 180 days of shared generic exclusivity. Eslicarbazepine acetate tablets are the generic of Sumitomo Pharma America’s Aptiom.

Accomplished physician-scientist brings more than 30 years of industry leadership experience and CNS drug development expertise. SEATTLE, April 29, 2025 /PRNewswire/ -- Transneural Therapeutics ...